News
Acetaminophen: A Viable Alternative for ... Available without prescription and with fewer side effects than ... (22 Jun 2017)
Flights can make aircrew sick, Stirling ... Flying a plane should come with a health warning, according to ... (22 Jun 2017)
Study uncovers link between male hormones ... Scientists from the University of Birmingham have discovered the ... (22 Jun 2017)
Does Roasting Level Affect the Antioxidant ... Researchers compared the caffeine and chlorogenic acid ... (22 Jun 2017)
Breast implants may impede ECG and lead to ... Breast implants may impede an electrocardiogram (ECG) and could ... (21 Jun 2017)

Do you want to keep working until you’re 70, or even 75? Then, it’s good to give this some thought before you turn 50. New research now calls for early planning, and at the same time shoots down prejudices against working seniors.

Published in Medical News

Authors conclude that proton-pump inhibitors should be co-prescribed in this age group to reduce the risk of bleeds.

Published in Medical News

A new analysis suggests that among older adults who take cardiovascular medications, those using non-selective beta-blockers may be at an increased of falling compared with those using selective beta-blockers. These types of drugs are already known to differ by their receptor binding properties and their systemic effects on the body.

Published in Medical News

Older people newly prescribed sleeping pills like benzodiazepines and ‘Z-drugs’ have over double the odds of a hip fracture in the first two weeks compared with non-users, according to a new study by researchers at Cardiff University and King’s College London.

Published in Medical News

An analysis of published studies found no evidence that low- dose aspirin buffers against cognitive decline or dementia or improves cognitive test scores.

Published in Medical News
Tuesday, 21 March 2017 12:17

Denosumab Found Safe in Long-Term Trial

A new study provides reassuring information about the short-term and long-term safety of denosumab, a monoclonal antibody that is used to treat postmenopausal osteoporosis.
Adverse events that had been noted in a pivotal clinical trial in women age 60 to 90 years old treated for 3 years showed no tendency to increase after a further 3 years of treatment, the study showed.

Published in Medical News
Page 1 of 4

TheSynapse Videos

0
0
0
0
0
0

Jamesco News

Has no content to show!

GSK

Vivian

TheSynapse Magazines

Latest news

Links

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Template Settings

Theme Colors

Cyan Red Green Oranges Teal

Layout

Wide Boxed Framed Rounded
Patterns for Layour: Boxed, Framed, Rounded
Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…